K*lebsiella pneumoniae* is a highly important bacterial pathogen that causes a wide range of community- and hospital-acquired infections, such as pneumonia, urinary tract infections, intra-abdominal infections and respiratory tract infections[@b1][@b2]. The emergence and rapid spread of carbapenem-resistant *K. pneumoniae* isolates such as the New Delhi Metallo-beta-lactamase-1 (NDM-1)-producing strains has caused great concern worldwide[@b3][@b4][@b5]. The NDM-1, an Ambler class B metallo-β-lactamase (MBL), is capable of hydrolyzing all β-lactams (including carbapenems) except monobactams. It was first identified in *K. pneumonia*e and *Escherichia coli* in India in 2008. To date, NDM-1 producing pathogens have been reported in more than 40 countries[@b6][@b7][@b8]. The successful persistence and transmission of this "superbug" remain largely unknown, but could be partly due to the ability of this pathogen to sense and react to environmental and host stress signals, which allow it to persist and disseminate in harsh conditions such as in various medical settings and inside the human host. Thus, understanding the ability of those pathogens to adapt to various stressors they encountered during environmental persistence could facilitate the comprehension of their pathobiology. In addition, identification of specific genomic variations and transcriptome patterns critical for drug resistance and environmental adaptation of the drug-resistant pathogenic bacteria is important for the development of more effective pathogen control strategies.

During spaceflight, a variety of physiological stressors associated with the space environment and spacecraft conditions could potentially contribute to detrimental alterations in the human immune system. At the same time, the bacteria introduced into the extraterrestrial environments by the space crew members inhabiting the stressful airspace environments might develop resistance traits which could be important to spaceflight missions and the general public medicine. Indeed, the recurrent isolation of various extremotolerant bacteria from spacecrafts emphasizes the possibility of those microorganisms gaining access to spacecrafts and being transferred to extraterrestrial environments[@b9][@b10][@b11]. Furthermore, it has been demonstrated that following spaceflight the gene expression pattern of *Salmonella enterica* serotype *Typhimurium* changed and the virulence of those bacteria increased[@b12]. However, the microbial mechanisms of resistance in those pathogenic bacteria during spaceflight remained largely unknown. The extreme conditions encountered by the microorganisms in air space could facilitate the occurrence of the environmental adaptation-associated genomic variations and transcriptomic changes in them, and that information could be useful for taking pre-emptive measures to manage medically important drug-resistant pathogens on earth. The Shenzhou-10 spacecraft, which was launched in June 11, 2013 and returned to earth after completion of its 15-day spaceflight, is China\'s fifth manned space mission and its longest so far, thus it provided us a unique opportunity to explore the underlying mechanisms important for bacterial adaptation to extreme environments.

In this study, we conducted comparative whole genome sequencing and RNA sequencing (RNA-Seq) analysis of a NDM-1- producing *K. pneumoniae* strain (ATCC BAA- 2146). The *K. pneumonia*e strains were cultivated in semisolid medium and the culture placed in the following conditions: on the ground (D strain), in simulated space condition (M strain), and in the Shenzhou 10 spacecraft (T strain). Comparative genomic analysis revealed 3 and 2 strain-specific mutations in M and T strains, respectively. The comparative transcriptomic analysis revealed different transcriptome patterns among the strains, especially with respect to the regulation of multiple metabolic pathways. Additionally, we found a few non-coding RNAs (ncRNAs) to be differentially regulated. Phenotype comparisons showed that the T strain exhibited elongated forms, reduced hydrogen peroxide (H~2~O~2~) tolerance and increased biofilm formation ability. Our results provide new insights into the environmental adaptability of drug-resistant *K. pneumoniae*. These findings could contribute to understanding the persistence and widespread of those highly drug-resistant pathogenic bacteria.

Results
=======

Phenotypic characteristics of *K. pneumoniae* strains
-----------------------------------------------------

The *K. pneumoniae* ATCC BAA-2146 was an ESBL-positive and NDM-1-producing strain. According to multilocus sequence typing (MLST), this strain belonged to sequence type 11 (ST11). Drug susceptibility testing results showed that the reference strain ATCC BAA-2146 was resistant to all antibiotics tested, and the drug resistance profiles of the recovered D, M and T strains remained unchanged ([Supplementary Table S1](#s1){ref-type="supplementary-material"}). No notable differences in colony morphology of the strains were observed under light microscopy. Field emission scanning electron microscopy (SEM) was further used to monitor single cell morphology of the strains and the results showed that the bacterial cell walls of all strains were intact. But interestingly, some of the cells of the T strain turned into elongated forms and adhered to each other under SEM ([Fig. 1](#f1){ref-type="fig"}). In the H~2~O~2~ sensitivity assay, the 1 mM and 5 mM H~2~O~2~ exposure resulted in slightly reduced survival for the T strain in comparison with the BAA-2146 control strain (*P* \< 0.001), whereas, the D and M strains showed no obvious differences in sensitivity to H~2~O~2~ when compared to the BAA-2146 strain ([Fig. 2a](#f2){ref-type="fig"}). The ability of *K. pneumoniae* to form biofilms is thought to be an important phenotype with respect to adaptability and virulence traits such as host colonization, antibiotic resistance, and environmental persistence, etc.[@b13][@b14]. We therefore performed biofilm assays to determine the biofilm formation abilities of the strains, and the results showed that the T strain showed enhanced biofilm-forming capacity compared to the BAA-2146 strain (*P* \< 0.001) while the D strain and the M strain showed similar biofilm-forming capacity with the reference strain BAA-2146 ([Fig. 2b](#f2){ref-type="fig"}). The fitness of the *K. pneumoniae* strains was further assessed by determining the growth rates of the strains in a nutrient LB medium as well as in chemically defined media (CDM), as this parameter also could contribute to environmental adaptability. All strains showed similar growth curves in LB medium ([Fig. 3a](#f3){ref-type="fig"}) and in CDM ([Fig. 3b](#f3){ref-type="fig"}). Furthermore, the growth curves were also similar when the bacteria were cultivated in LB medium at different temperatures including 30°C, 37°C and 40°C ([Fig. 3c, 3a and 3d](#f3){ref-type="fig"}). To better understand the phenotypic changes in the strains, we also performed carbon source utilization assays and chemical sensitivity assays using the 96-well Biolog GEN III MicroPlate. Among the 71 carbon source utilization assays, the α-D-Lactose utilization ability was found to be defective in all three strains (including the D, M and T strains) as compared to the reference strain BAA-2146. Interestingly, the M strain was shown to gain the ability to use D-Mannose. Among the 23 chemical sensitivity assays, no obvious changes were observed for all three strains compared to the reference strain ([Supplementary Table S2](#s1){ref-type="supplementary-material"}).

Whole genome sequencing statistics
----------------------------------

The basic whole genome sequencing statistics were shown in [Table 1](#t1){ref-type="table"}. The sequencing depth ranged between 127× and 128× and read mapping results reported nearly complete genome coverage (\~99.99%) for all three strains. [Fig. 4](#f4){ref-type="fig"} showed the circular representation of the genome features including the COG annotated coding sequences, KEGG enzymes, RNA genes, GC content, GC skew, strain-specific SNPs, etc. As shown in [Supplementary Fig. S1](#s1){ref-type="supplementary-material"}, all three samples had similar mapping coverage across the reference genome and the coverage was higher for the regions closer to the origin of replication, probably because of a higher speed of the DNA replication than that of cellular doubling during exponential growth.

Identification of the mutations in D, M and T strains compared to reference strain ATCC BAA-2146
------------------------------------------------------------------------------------------------

A total of 34 mutations (excluding the synonymous mutations) were identified in all strains ([Supplementary Tables S3](#s1){ref-type="supplementary-material"}), among which, 25 mutations were shared by all three strains ([Supplementary Tables S4](#s1){ref-type="supplementary-material"}). No strain-specific mutation was identified in the D strain, while 3 and 2 strain-specific mutations were identified in the T and M strains, respectively. In addition, a few mutations were shared by T and M, T and D, or M and D strains ([Table 2](#t2){ref-type="table"}). PCR and sequencing analysis confirmed that these mutations were not sequencing or assembly errors.

Drug resistance determinants of *K. pneumoni*ae strains
-------------------------------------------------------

Electronic PCR was conducted for ATCC BAA-2146, D, M and T strains to analyze drug resistance determinants conferring resistance to carbapenems, folate pathway inhibitors, fluoroquinolones, aminoglycosides, etc. The drug resistance-associated genes and gene mutations detected in the D, M and T strains were identical to those of the reference strain ATCC BAA-2146 ([Supplementary Table S5](#s1){ref-type="supplementary-material"}).

RNA-Seq mapping statistics
--------------------------

Approximately 96% of the sequencing reads could be mapped to ATCC BAA-2146 (CP006659) reference genome ([Table 3](#t3){ref-type="table"}). The uniquely mapped reads for D, M, and T were 96.0%, 95.9% and 96.3% respectively. The number of reads mapped each gene ranged from 1 to 449,669 with a median of 206, 209 and 214 for D, M and T, respectively. In addition, the RPKM for D, M and T was 48.8, 49.5 and 52.3 for D, M and T respectively. The distribution of the number of mapped reads and RPKM values across all three samples was displayed in [Supplementary Fig. S2](#s1){ref-type="supplementary-material"}. The expression of total genes and the differentially expressed genes identified among D, M and T strains (fold changes \>2) were shown in [Fig. 5](#f5){ref-type="fig"}.

Comparative transcriptomic analysis
-----------------------------------

By using the KEGG orthology based annotation system to identify metabolic pathways, we identified extensive changes in the transcriptomes of the M and T strains in comparison to the D strain. Expression of the differentially expressed genes identified among D, M and T strains (including: T strain vs. D strain, M strain vs. D strain, and T strain vs. M strain) were shown in [Supplementary Tables S6--S8](#s1){ref-type="supplementary-material"}. Compared to the D strain transcriptome, the T strain transcriptome was characterized by regulation of a number of genes involved in fatty acid degradation (*P* = 0.0464189), microbial metabolism in diverse environments (*P* = 0.0464189), and phenylalanine metabolism (*P* = 0.0464189). Among those three categories, the majority of the genes involved in fatty acid degradation and phenylalanine metabolism were down-regulated, while the genes involved in microbial metabolism in diverse environments include many up-regulated and many down-regulated genes ([Supplementary Table S6](#s1){ref-type="supplementary-material"}). Compared to the D strain transcriptome, the M strain transcriptome showed that many genes associated with tyrosine metabolism (*P*\<0.001), degradation of aromatic compounds (*P* = 0.003804639), and microbial metabolism in diverse environments (*P* = 0.005292205) were regulated ([Supplementary Table S7](#s1){ref-type="supplementary-material"}), and the majority of those genes were up-regulated. Genes altered in their expression common to both M strain and T strain transcriptomes included a variety of genes involved in microbial metabolism in diverse environments. In comparison to the M strain, the T strain transcriptome was further characterized by regulation of a number of genes involved in citrate cycle (*P* = 0.0179529) and phenylalanine metabolism (*P* = 0.0404427). In addition, many more genes involved in microbial metabolism in diverse environments (*P* = 0.0404427) were regulated in the T strain than in the M strain. Additionally, we found a few ncRNAs to be differentially regulated in the T and M strains as compared to the D strain. Some of those ncRNAs (including GlmZ RNA activator of *glmS* mRNA and RtT RNA) were similarly regulated in both M and T strains. But interestingly, *sroC* RNA was down-regulated in the T strain but up-regulated in the M strain ([Table 4](#t4){ref-type="table"}). The number of mapped reads and estimation of gene expression (RPKM) values between the D, M and T strains were displayed in a boxplot as shown in [Supplementary Fig. S2](#s1){ref-type="supplementary-material"}. Ten genes were selected for quantitative RT-PCR analysis in parallel with the RNA-Seq analysis, and the results validated that gene expression fold changes from RNA-Seq analysis for specific genes were well correlated with transcript levels measured using real-time quantitative RT-PCR (qRT-PCR) analysis, supporting that RNA-Seq provides reliable quantitative estimates of transcript levels ([Supplementary Tables S9 and S10](#s1){ref-type="supplementary-material"}). The Orthologus Groups (COG) enrichment analysis was also determined to show the distribution of differentially expressed genes (DEGs) in COG functional categories ([Fig. 6](#f6){ref-type="fig"}). A large number of the genes that were differentially expressed in the T strain vs. D strain (T/D) play putative roles in the following two COG categories: amino acid transport and metabolism (*P* = 0.01814), and carbohydrate transport and metabolism (*P* = 0.04659). In addition, many genes that were differentially expressed in the M strain vs. D strain (M/D) belonged to the following three COG categories: Cell motility, Secondary metabolites biosynthesis (*P* = 0.004304), transport and catabolism (*P* = 0.007086), and Inorganic ion transport and metabolism (*P* = 0.0346).

Discussion
==========

The explanation for the epidemiological success of highly drug-resistant bacterial pathogens, such as the NDM-1-producing *K. pneumoniae* strains, is complex. In general, the antibiotic resistance phenotype of bacteria is attributed to their capacity to acquire and express genes associated with a wide range of antibiotic resistance functions, as well as their intrinsic properties such as porins and gene mutations, etc. In this study, the reference strain ATCC BAA-2146 was shown to possess a large number of previously reported genes associated with resistance to β-lactams, fluoroquinolones, aminoglycosides and folate pathway inhibitors[@b15][@b16][@b17][@b18][@b19]. Among the more recently reported carbapenemases genes (such as *bla*~IMP~, *bla*~VIM~, *bla*~NDM-1~, *bla*~KPC~, and *bla*~OXA-48~, etc.), only NDM-1 was detected in ATCC BAA-2146. We also identified a *gyrA* mutation T247A (Ser83Ile) which was shown to be associated with fluoroquinolone resistance[@b16]. In this study, the D, M and T strains all remained their drug resistance phenotype and maintained all those drug resistance-associated genes detected in the reference strain ATCC BAA-2146, suggesting that this highly drug-resistant *K. pneumoniae* strain did not lose resistance to those drugs while grown in extreme conditions. Based on MLST genotyping analysis, ATCC BAA-2146 belonged to ST11, which was reported to be the most dominant clone among the carbapenem-resistant *K. pneumoniae* isolates in China[@b20]. Thus this drug-resistant *K. pneumoniae* strain could be intrinsically highly transmissible.

Morphological analysis revealed that some cells of the T strain were elongated and adhered to each other under SEM, suggesting that certain genes involved in maintaining bacterial morphology and adherence ability could be affected or regulated. Normally, the function and morphology of the bacteria are maintained by well-coordinated equilibrium of their fusion and fission activities. Therefore, the explanations for the mechanism underlying the formation of elongated bacteria could be an enhanced fusion process, a blocked fission process, or a combined action of the two. Since we did not identify mutations in genes directly involved in bacterial fission or fusion function in the T strain, we thus hypothesize that certain mutations which occurred in the intergenic regions or ncRNAs could play regulatory roles on genes associated with these morphological changes in the T strain. We also predict that the increased bacterial fusion and adherence capabilities might be beneficial for the pathogen to form biofilm under stress conditions in order to promote bacterial survival. The elongated forms of the bacteria have previously been observed in bacteria being treated by certain antibiotics. For example, in one study, the scanning electron microscopy analysis demonstrated that *Pseudomonas aeruginosa* became elongated after exposure to ciprofloxacin[@b21]. Another study also showed that most of the *P. aeruginosa* cells turned into elongated forms and adhere to each other when exposed to nalidixic acid[@b22]. Thus, this morphological change could be a typical response of pathogenic bacteria towards various stressors.

Bacterial cells are constantly challenged by various environmental stressors from their natural habitats. Similar to many pathogens, *K. pneumoniae* faces several challenges during infection and colonization of the human body. Among these, the ability of the pathogen to tolerate oxidative stress is critical for their survival since the transition from aerobic to microaerophilic conditions or the transition from a microaerophilic to oxidative stress environment is frequently encountered by the pathogen during infection. Oxidative stress on aerobic bacteria is mainly mediated by partially reduced oxygen species, or reactive oxygen species, most notably superoxide and H~2~O~2~, which are by-products of aerobic metabolism. These reactive oxygen species can cause damage to DNA, proteins and membranes. As a result, all aerobic bacteria possess various mechanisms to scavenge superoxide and H~2~O~2~, thus protecting the cells from being damaged by these reactive oxygen species. Thus, the response of drug-resistant bacteria under oxidative stress conditions is of particular interest. Our study revealed that the T strain exhibited a slightly reduced tolerance toward H~2~O~2~, this could be partly explained by the decreased expression of the universal stress response gene as well as a few ncRNAs such as *sroC* RNA, 6S/SsrS RNA, and the bacterial small signal recognition particle RNA in this strain, since those genes and ncRNAs were shown to be involved in stress tolerance or bacterial fitness[@b23][@b24][@b25][@b26][@b27]. Interestingly, it was demonstrated that *S. Typhimurium* inside macrophages led to repression of the expression of the *sroC* and 6S/SsrS RNA genes, suggesting that those ncRNAs may also direct pathogen adaptation to a non-proliferative state inside the host cell[@b27]. Taken together, we hypothesize that those ncRNAs could also play critical roles during environmental adaptation of *K. pneumoniae*.

The bacterial biofilm consists of an aggregate of cells contained within a matrix of surface polysaccharides, proteins and DNA. The ability to produce a biofilm results in enhanced resistance to host defense factors, antimicrobials, as well as various environmental stressors, thus it has been increasingly recognized as an important virulence property. An observation by Wu et al. showed that certain *K. pneumoniae* strains such as hvKP strains produced more biofilm than cKP strains, suggesting that biofilm formation may be a contributing factor to the increased virulence of the hvKP strains[@b28]. In this study, though the T strain showed slightly decreased tolerance towards H~2~O~2~, it exhibited increased biofilm production. The similar growth rates of the reference strain ATCC BAA-2146 as well as the D, M and T strains in LB medium and CDM ruled out the possibility that the increased biofilm production in the T strain was due to a change in growth. The mechanism underlying the increase biofilm formation in the T strain remains currently unclear, but could be associated with increased expression of certain regulatory genes involved in surface polysaccharide formation as suggested by the increased adherence between bacterial cells under SEM. We also noticed that in the T strain a large number of up-regulated genes were involved in the citrate cycle, which is a central metabolic pathway that facilitates the adaption of bacteria to environmental stress. This finding is also consistent with a previous study which showed an increased abundance of genes involved in the citrate cycle in *E. coli* when grown as a biofilm[@b29]. The results from that study and ours suggest that pathogens grown as a biofilm could still be energetically viable by using amino acids as an indirect carbon source through citrate cycle.

Using the 96-well Biolog GEN III MicroPlate for further phenotypic characterization of the strains, we observed that the α-D-Lactose utilization ability was defective in all three strains as compared to the reference strain BAA-2146, and the M strain gained the ability to use D-Mannose. Regulation of metabolic pathways has been demonstrated to be an important stress response of pathogenic bacteria, and a variety of transcriptional regulators such as LysR, RutR and Atf1 have been shown to play central roles during this process[@b30][@b31][@b32][@b33][@b34]. For example, LysR was shown to be an important regulatory component of *P. aeruginosa* adaptation during oxidative stress[@b35]. RutR was demonstrated to be involved in glutamate-dependent acid resistance of *E. coli* for survival under acidic conditions[@b34]. In addition, many regulatory networks of the pathogen contain ncRNAs, which could also regulate the expression of key protein-coding genes during the adaptive response to environmental stimuli[@b36][@b37]. We identified a non-synonymous mutation in Kpn2146_2018 (P184S), which belongs to the transcriptional regulator LysR family. In addition, a couple of mutations were also identified in the intergenic regions near Kpn2146_2018 and Kpn2146_5387, the latter of which is also a transcriptional regulator, RutR. We also identified two M strain-specific mutations in the intergenic regions between Kpn2146_3273 (RtT RNA) and Kpn2146_3274 (tRNA-Tyr) (T-39A and C-37T). Those mutations within or nearby those transcriptional regulators and non-coding RNA regions could be associated with the regulation of metabolic pathways through up-regulating or down-regulating their targets in the *K. pneumoniae* strains during pathogen environmental adaptation.

The study of genomic variations as a function of pathogen adaptation to a specific niche could reveal important insights into how they sense and respond to varied habitats. Our comparative genomic analysis revealed only a few mutations specific to each strain, but a large number of mutations were shared by the D, M and T strains, suggesting the all three strains underwent adaptation genomic variations while being cultivated in different environments, though each strain were exposed to different combination of stressors and the strength of each stressors they encounter might be different. We also noticed that a large proportion of the mutations occurred in the intergenic regions or ncRNAs, suggesting that those mutations could play important regulatory roles on their down-stream genes or more distantly located genes, which could be involved in stress response and environmental adaptation. There were also some mutations occurring in hypothetical proteins such as Kpn2146-1328, Kpn2146-2411, and Kpn2146-2412, the roles of which in pathogen environmental adaption await further studies.

Comparative transcriptomic analysis revealed that the gene expression patterns of the three strains were significantly different from each other. The transcriptomes of both the M and T strains indicated significant changes in microbial metabolism compared to the D strain. Many more genes were regulated in the T strain compared to the M strain, suggesting that the T strain experienced more stress during spaceflight than the M strain which was cultivated in a simulated space condition with 10^−3^ g microgravity. Furthermore, a large proportion of the differentially expressed genes in the T strain, as compared to both D and M strains, were involved in a variety of different metabolic pathways including the following COG categories: amino acid transport and metabolism, and carbohydrate transport and metabolism. These results suggest that in response to environmental stress, pathogenic bacteria including highly drug-resistant ones exhibit a great flexibility and adaptability to survive successfully through regulation of multiple physiological functions and cellular pathways, among which the regulation of metabolism pathways seems to play a very important role. Using RNA-Seq, we also identified a few previously reported or putative ncRNAs, which could play critical roles during the environmental adaptation of *K. pneumoniae*. As the RNA isolation procedure used in this study selected against small RNA molecules, it is likely that additional small ncRNAs not detected here could also be transcribed during stress responses of the *K. penumoniae*. Nevertheless, the results from this study provide powerful evidence showing that RNA-Seq allow quantitative characterization of bacterial transcriptomes and provide a useful tool for exploring transcriptional regulatory networks in bacteria.

In summary, our comparative genomic and transcriptomic analysis of a NDM-1 *K. pneumoniae* strain being cultivated in different conditions support the possible resistance or adaptation of the highly drug-resistant pathogenic bacteria towards the extreme environments such as the conditions in spacecrafts, which could have important impacts on the microbial ecology of the extraterrestrial space. The present study could also serve as a basis for future studies examining the complex network systems that regulate bacterial adaptation to extreme environments. Furthermore, the insights we gained from the observations of persistence and pathogenesis-related genomic variations and transcriptomic changes of the NDM-1 *K. pneumoniae* strain in response to spaceflight could also facilitate the development of novel or alternative therapeutic methods needed to treat the recalcitrant infections caused by those highly drug-resistant *K. pneumoniae* strains. Finally, the data obtained from this study could also be important for future infectious disease risk assessment and prevention during spaceflight missions and in general public health as well.

Methods
=======

Bacterial strains and culture conditions
----------------------------------------

The reference *K. pneumoniae* strain KP ATCC BAA- 2146 was used in the study. *K. pneumonia*e was cultivated in semisolid medium (with 0.5% agar) for 15 days at 21°C, and the culture were placed in the following conditions: on the ground (D strain), in simulated space condition with rotation at 30 rpm and 10^−3^ g microgravity (M strain), and in the Shenzhou 10 spacecraft (T strain). For phenotypic analysis, the *K. pneumoniae* strains were routinely grown in Luria-Bertani (LB) broth. Agar was added to a final concentration of 1.5% when necessary. For growth curve measurement, the strains were grown at designated temperature (30°C, 37°C or 40°C) with shaking (180 rpm). The CDM used for growth curve measurement was described previously[@b38].

Drug susceptibility testing
---------------------------

Drug susceptibility testing (DST) for the *K. pneumoniae* strains was performed using the bioMe\'rieux VITEK-2 AST-GN13 system following manufacturer\'s instructions as described previously[@b16]. The following 18 drugs were tested: ampicillin (AMP), piperacillin/tazobactam (TZP), ampicillin/sulbactam (SAM), cefazolin (CFZ), ceftriaxone (CRO), ceftazidime (CAZ), cefepime (FEP), cefotetan (CTT), ertapenem (ETP), imipenem (IMP), aztreonam (ATM), ciprofloxacin (CIP), levofloxacin (LVX), gentamicin (GM), tobramycin (TOB), amikacin (AMK), trimethoprim-sulfamethoxazole (SXT), furadantin (FD). The ESBLs were detected by the bioMe\'rieux VITEK-2 AST-GN13 test. *E. coli* strains ATCC 25922 and ATCC 35218, *K. pneumoniae* strain ATCC 700603 and *P. aeruginosa* strain ATCC 27853 were used as quality control strains for the DST.

H~2~O~2~ sensitivity assays
---------------------------

To measure the susceptibility of *K. pneumoniae* to oxidative stress, H~2~O~2~ sensitivity assays were conducted according to the method reported by Cumley et al. with minor modifications[@b39]. Briefly, overnight-grown bacteria were diluted 100 folds in fresh LB medium and grown to early stationary phase at 37°C with vigorous shaking. Bacteria were resuspended in 0.1 M sodium phosphate buffer (pH 7.4) with increasing concentrations of H~2~O~2~ (0 mM, 1 mM, 5 mM) without agitation. After 2 h incubation at 37°C, cultures were diluted and plated onto LB plates. All experiments were repeated at least three times.

Biofilm formation assay
-----------------------

Bacteria were diluted 100 folds in LB broth, and was then inoculated into each well of a 96-well polystyrene flat-bottom microtiter plates and statically incubated at 37°C for 24 h. Then the wells were washed with phosphate-buffered saline (PBS) to remove unattached cells. Crystal violet (0.1% w/v; Sigma) was used to stain the attached cells for 30 min at 25°C. The plates were then washed with PBS and left to dry for a further 10 min, and the stained biomass was solubilized in 1% (w/v) SDS. The absorbance of each well was determined at OD~595\ nm~. All experiments were repeated at least three times.

Scanning electron microscopy
----------------------------

Bacterial cells, grown in LB medium, were fixed with 2.5% (vol/vol) glutaraldehyde in phosphate-buffered saline (PBS, pH 7.4) and subsequently post-fixed in 1% (wt/vol) osmium tetroxide. The samples were then dehydrated in acetone, critical-point dried, and coated with gold-palladium. The specimens were finally examined with a FEI Quanta 200 SEM scanning electron microscope (USA).

Carbon source utilization assays and chemical sensitivity assays
----------------------------------------------------------------

The Biolog GEN III MicroPlate was used to analyze the *K. pneumoniae* strains in 94 phenotypic tests, which including 71 carbon source utilization assays and 23 chemical sensitivity assays. Briefly, the bacterial culture were picked up from the surface of the BUG+B agar plate (Biolog, CA, USA) using a sterile cotton-tipped swab and inoculated into the IF-A Inoculum (Biolog, CA, USA). The target cell density of Inoculum was set to 90--98% T by turbidimeter (BioMérieux, Lyon, Fance). Then 100 µl of the inoculum was added into each well of the 96 GEN III MicroPlate^TM^ (Biolog, CA, USA). After incubating the culture for 24 hours at 37°C, the OD~590~ readings were measured with a BIOLOG microplate reader automatically and further confirmed visually.

Genome sequencing
-----------------

Genome sequencing was performed by Beijing Genomics Institute (BGI, China). Briefly, the genomic DNA for each bacterium was prepared by conventional phenol-chloroform extraction methods. A 500 bp paired-end library was constructed for each purified DNA sample following the standard Illumina paired-end protocol with a low-cycle polymerase chain reaction during the fragment enrichment, and sequencing was performed on the Illumina Hiseq 2000 with 90 cycles. Low quality reads were filtered using the DynamicTrim and LengthSort Perl scripts within SolexaQA. Short reads were assembled using SOAP*denovo* version 2.04[@b40] and the gaps were closed by GapCloser version 1.12.

Genetic mutations detection and phylogenetic analysis
-----------------------------------------------------

First, the short reads were aligned onto the *K. pneumoniae* ATCC BAA -2146 genome reference using the SOAP2 program[@b41]. Second, SOAPsnp was used to score SNPs from aligned reads[@b42]. SOAPsnp results were filtered as follows: (1) The read coverage of the SNP site was more than three, (2) The Illumina quality score of either allele was more than 30, and (3) The count of all mapped best base was more than two times the count of all mapped second best base. In addition, BWA 0.6.2 and SAMtools 0.1.18 were used to confirm the SNP results. The Illumina reads were first aligned by BWA with default parameters for each sample. The aligned results were piped to SAMtools to perform SNP and Indel analysis.

Electronic PCR for MLST genotyping and identification of drug resistance-associated genes
-----------------------------------------------------------------------------------------

MLST with seven genes (*gapA*, *infB*, *mdh*, *pgi*, *phoE*, *rpoB* and *tonB*) was performed on isolates according to the protocol described on the *K. pneumoniae* MLST website ([www.pasteur.fr/mlst](http://www.pasteur.fr/mlst)). STs were assigned by using the MLST database ([www.pasteur.fr/mlst/Kpneumoniae.html](http://www.pasteur.fr/mlst/Kpneumoniae.html)). Electronic PCR was used to extract the drug resistance-associated genes, then the DNA sequences were annotated using the BLAST program at <http://www.ncbi.nlm.nih.gov.Mutations> in the *gyrA* and *parC* genes were identified by comparing the DNA sequences with *gyrA* and *parC* sequences of the *K. pneumoniae* (GenBank accession numbers DQ673325 and NC009648 for *gyrA* and *parC* respectively).

RNA-Seq and comparative transcriptomic data analysis
----------------------------------------------------

Total RNA isolation as well as construction and sequencing of cDNA libraries of the *K. pneumoniae* strains were conducted by BGI (China). Briefly, total RNA samples were isolated using a RNeasy Protect Bacteria Mini Kit (QIAGEN, Germany) according to the manufacturer\'s instructions. Sequencing was carried out by running 90 cycles on the Illumina Hiseq 2000. Paired-end reads were mapped to *K. pneumoniae* ATCC BAA -2146 (CP006659) reference sequence using Bowtie2[@b43]. The number of reads mapped to each gene was counted by using HTSeq-count (<http://www-huber.embl.de/users/anders/HTSeq>). The edgeR package[@b44] from R/BioConductor was used to normalize the mapped count data and for differential gene expression analysis. Fold changes with FDR ≤ 0.001 were considered to be statistically significant. RPKM (Reads Per kb per Million reads) values were provided to enable comparison of relative transcript abundance among difference samples.

Functional annotation and enrichment analysis
---------------------------------------------

KOBAS 2.0 (KEGG Orthology Based Annotation System) was used to identify metabolic pathways and to calculate the statistical significance of each pathway[@b45]. The COG annotation was performed using the Blastall software against the Cluster of Orthologus Groups (COG) database. COG enrichment analysis was determined by comparing the prevalence of differentially expressed genes assigned to a specific COG category to the prevalence of genes in the whole genome assigned to that COG category with a Fisher\'s exact test.

Quantitative RT-PCR of selected targets
---------------------------------------

To validate whether RNA-Seq provides reliable quantitative estimates of transcript levels, qRT-PCR analysis was conducted for 10 randomly selected genes. cDNA samples were analyzed by quantitative PCR with KAPA SYBR FAST qPCR Kit (KAPA Biosystems) on ABI 7300 system (Applied Biosystems). Data were analyzed by the 2^−ΔΔCT^ method and normalized to the *gapdh*. Each experiment was performed in triplicates and repeated at least three times.
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![Morphology of the *K. pneumoniae* strains.\
(a) Scanning electron micrographs of the *K. pneumoniae* strains. (b) Colonies of the strains on LB agar plates. Scale bar, 5 μm.](srep06216-f1){#f1}

![Oxidative stress tolerance and biofilm formation ability of *K. pneumoniae* strains.\
(a) Survival of *K. pneumoniae* strains in oxidative stressed environment. The ATCC BAA-2146, D, M and T strains were incubated with different concentrations of H~2~O~2~ in sodium phosphate buffer, and then tested for their survival on LB plates. Growth is expressed as relative survival after 2 h incubation with H~2~O~2~. (b) Biofilm assays of *K. pneumoniae* strains. OD~595~ readings were measured for each strain to determine the amount of biofilm formed. Data represent one of three independent experiments.](srep06216-f2){#f2}

![Growth curves of the *K. pneumoniae* strains in LB medium (a, c and d) or CDM (b).\
Overnight-grown bacteria were diluted 100 folds in fresh LB medium or CDM and were cultivated at designated temperature with shaking (180 rpm). OD~600~ readings were measured at designated time points for each strain. The data represent one of two independent experiments performed in triplicate, with s.d. indicated by error bars.](srep06216-f3){#f3}

![Circular representation of the genome features.\
Genome sequences (ring 1), COG Annotated coding sequences (rings 2 + 3), KEGG enzyme (ring 4), RNA genes (ring 5: red, rRNA; blue, tRNA), GC content (rings 6), GC skew (ring 7), strain-specific SNPs (ring 8) are shown. All strain-specific SNPs from D (yellow), M (red), and T (blue) are shown on ring 8. Very short features were enlarged to enhance visibility. Clustered genes and SNPs, such as several rRNA genes, may appear as one line due to space limitations. The image was created by using the software Circos.](srep06216-f4){#f4}

![Expression of total genes (a) and the differentially expressed genes (b) identified among D, M and T strains (Fold changes \>2).\
The heatmap was generated from hierarchical cluster analysis of genes. The RPKM values were mean-centered and normalized across samples, with each row representing a different gene.](srep06216-f5){#f5}

![Distribution of differentially expressed genes in COG functional categories.\
The y-axis represents the number of genes in each COG category.](srep06216-f6){#f6}

###### Statistics of whole genome sequencing

  Sample                     D strain    M strain    T strain
  ------------------------- ----------- ----------- -----------
  **Raw read statistics**                                 
  Total reads                 4011112     4038889     4038889
  Total base pairs              722         727         727
  Sequencing depth (X)          127         128         128
  Genome coverage (%)          99.99       99.99       99.99
  **Assembly statistics**                                 
  Chromosome size            5,674,681   5,671,078   5,671,920
  No. of scaffolds              72          73          66
  Largest scaffold length     840,095     840,520     839,882
  N50 scaffold length         236,010     236,344     288,168
  G+C content (%)              57.0        57.0        57.0

###### Comparative analysis of SNPs and Indels identified in D, M, and T strains. Synonymous SNPs were excluded

  Mutation position                                                                                         Gene name                                                                         Product                                                                 Base mutation   AA mutation    Type of mutation
  ------------------------------------------------------------------------------------------------ --------------------------- ------------------------------------------------------------------------------------------------------------------------------------- --------------- ------------- --------------------
  **SNPs and Indels specific to T strain**                                                                                                                                                                                                                                                                   
  G1539668C                                                                                               Kpn2146_1513                                                          D-3-phosphoglycerate dehydrogenase                                                        G20C            R7P         Non-synonymous
  T2546875G                                                                                         Kpn2146_2552/Kpn2146_2553                                        4-carboxymuconolactone decarboxylase/Hypothetical protein                                           T-327G                     Intergenic regions
  G4946124A                                                                                               Kpn2146_5015                                                              small subunit ribosomal RNA                                                          G1400A                              
  **SNPs and Indels specific to M strain**                                                                                                                                                                                                                                                                   
  T3252757A                                                                                         Kpn2146_3273/Kpn2146_3274                                                          RtT RNA/tRNA-Tyr(GTA)                                                              T-39A                     Intergenic regions
  C3252759T                                                                                         Kpn2146_3273/Kpn2146_3274                                                          RtT RNA/tRNA-Tyr(GTA)                                                              C-37T                     Intergenic regions
  **SNPs and Indels specific to D strain**                                                                                                                                                                                                                                                                   
  None                                                                                                                                                                                                                                                                                                       
  **Non-synonymous SNPs and Indels shared by T strain and M strain and not present in D strain**                                                                                                                                                                                                             
  G2613880A                                                                                         Kpn2146_2620/Kpn2146_2621                                        Ambler Class A beta lactamase SHV-11/Hypothetical protein                                           G-274A                     Intergenic regions
  **SNPs and Indels shared by T strain and D strain and not present in M strain**                                                                                                                                                                                                                            
  C5323238G                                                                                         Kpn2146_5387/Kpn2146_5388                    Transcriptional regulator RutR of pyrimidine catabolism (TetR family)/Putative acetyltransferase                        C-289G                     Intergenic regions
  **SNPs and Indels shared by M strain and D strain and not present in T strain**                                                                                                                                                                                                                            
  G2610928T                                                                                               Kpn2146_2617                                                                 Hypothetical protein                                                               G112T          L38I         Non-synonymous
  G2612995C                                                                                         Kpn2146_2619/Kpn2146_2620   DeoR family transcriptional regulator probably involved in glycerate glycolaldehyde metabolism/Ambler Class A beta lactamase SHV-11       G-1C                      Intergenic regions

###### Summary of RNA sequencing data

                                      D           M            T                                 
  ---------------------------- --------------- -------- --------------- -------- --------------- --------
  Total reads                    13,367,754     100.0%    13,887,820     100.0%    13,284,972     100.0%
  Total base pairs              1,203,097,860   100.0%   1,249,903,800   100.0%   1,195,647,480   100.0%
  Total mapped reads             12,831,916     96.0%     13,321,176     95.9%     12,796,903     96.3%
  Perfect match                  10,367,952     77.6%     10,822,875     77.9%     10,284,372     77.4%
  ≤5bp mismatch                   2,463,964     18.4%      2,498,301     18.0%      2,512,531     18.9%
  Unique match                   12,829,558     96.0%     13,317,899     95.9%     12,793,482     96.3%
  Multi-position match              2,358        0.0%        3,277        0.0%        3,421        0.0%
  Total unmapped reads             535,838       4.0%       566,644       4.1%       488,069       3.7%
  Reads that aligned to rRNA       10,366        0.2%       11,075        0.2%        4,232        0.1%

###### Non-coding RNAs differentially expressed in different *K. pneumoniae* strains

  Up/down                                 LogFC      Gene name     Length                       Product
  ------------------------------------- ---------- -------------- -------- -------------------------------------------------
  **ncRNAs in T strain vs. D strain**                                                               
  up                                     1.115428   Kpn2146_0162    212             GlmZ RNA activator of glmS mRNA
  up                                     1.34515    Kpn2146_1637    166                         RtT RNA
  up                                     1.527822   Kpn2146_1634    170                         RtT RNA
  up                                     1.722864   Kpn2146_4340    157                      sok antitoxin
  up                                     2.218488   Kpn2146_1640    169                         RtT RNA
  up                                     2.243956   Kpn2146_1642    169                         RtT RNA
  down                                   −2.14516   Kpn2146_1562    162                        sroC RNA
  **ncRNAs in M strain vs. D strain**                                                               
  up                                     1.066489   Kpn2146_1199     97     Bacterial small signal recognition particle RNA
  up                                     1.091426   Kpn2146_0336    148                  sraL Hfq binding RNA
  up                                     1.136683   Kpn2146_0162    212             GlmZ RNA activator of glmS mRNA
  up                                     1.182549   Kpn2146_1634    170                         RtT RNA
  up                                     1.227269   Kpn2146_1562    162                        sroC RNA
  up                                     1.289375   Kpn2146_3220    108                        RprA RNA
  up                                     1.29224    Kpn2146_0026    119                       Spot 42 RNA
  up                                     1.305698   Kpn2146_1642    169                         RtT RNA
  up                                     1.442965   Kpn2146_1640    169                         RtT RNA
  up                                     1.508266   Kpn2146_1637    166                         RtT RNA
  up                                     2.056248   Kpn2146_4589    184                       6S/SsrS RNA
  **ncRNAs in T strain vs. M strain**                                                               
  up                                     1.089629   Kpn2146_2396    1910                group II intron S.ma.I1
  up                                     1.117141   Kpn2146_2146    1910                group II intron S.ma.I1
  up                                     1.370092   Kpn2146_4340    157                      sok antitoxin
  down                                   −1.02646   Kpn2146_3275    132                         RtT RNA
  down                                   −1.26951   Kpn2146_2450    118        Fumarate/nitrate reductase regulator sRNA
  down                                   −1.37514   Kpn2146_4084    148            Glm Y RNA activator of glmS mRNA
  down                                   −1.38085   Kpn2146_0026    119                       Spot 42 RNA
  down                                   −1.56665   Kpn2146_4589    184                       6S/SsrS RNA
  down                                   −1.73232   Kpn2146_1199     97     Bacterial small signal recognition particle RNA
  down                                   −1.90215   Kpn2146_0595     87                    C4 antisense RNA
  down                                   −2.2773    Kpn2146_5143     66                        RyhB RNA
